SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001654954-17-004188
Filing Date
2017-05-08
Accepted
2017-05-08 17:22:51
Documents
1
Period of Report
2017-05-08

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY 14A navb_pre-14a.htm PRE 14A 1267776
  Complete submission text file 0001654954-17-004188.txt   1268906
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35076 | Film No.: 17823515
SIC: 2835 In Vitro & In Vivo Diagnostic Substances